NCT00339131View on ClinicalTrials.gov

ULTRATRACE Iobenguane I 131 in Patients With Malignant Pheochromocytoma, Paraganglioma, or Metastatic Carcinoid

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 30, 2006

Study Completion Date

January 31, 2007

Conditions
PheochromocytomaParagangliomaCarcinoid
Interventions
DRUG

Ultratrace iobenguane I 131

Sponsors
All Listed Sponsors
lead

Molecular Insight Pharmaceuticals, Inc.

INDUSTRY